A patient with poorly controlled diabetes has developed end-stage renal failure and consequent anemia. When reviewing this patients treatment plan, the nurse should anticipate the use of what drug?

Question

Quizplus · Accepted Answer

The availability of recombinant erythropoietin (epoetin alfa [Epogen, Procrit], darbepoetin alfa [Aranesp]) has dramatically altered the management of anemia in end-stage renal disease. Heparin, vitamin $\mathrm{K}$, and magnesium are not indicated in the treatment of renal failure or the consequent anemia.

A Patient with Poorly Controlled Diabetes Has Developed End-Stage Renal K\mathrm{K}K

A Patient with Poorly Controlled Diabetes Has Developed End-Stage Renal $\mathrm{K}$